Hot Dow Dividend Stocks To Own Right Now

Although the aging bull market has some investors turning more cautious, there are still a lot more bulls than bears around, and MoneyShow's Tom Aspray believes this dynamic needs to change in order to fuel the market's next leg up.

Last Monday's loss of more than 1% in the S&P 500 and the 2014 new daily closing low got the market's attention but the bulls quickly took over as stocks closed the week well above the worst levels.

The financial media continues to parade a host of bullish analysts ignoring that a few had been predicting horrible crashes over the past six months. The individual investor has become a bit more cautious as according to AAII, just 38.9% are now bullish as opposed to 55% the day after Christmas. It would appear that most have moved to the correction camp as the number of bears is still low at 21.5%.

Though this reading makes a correction less likely over the short term, it is still too high. At last August's lows, when the Spyder Trust (SPY) was at $163, only 29% bullish. Friday's weaker than expected Consumer Sentiment reading from the University of Michigan may help to dampen some investor bullishness.

Best India Stocks To Own For 2015: iShares Russell 2000 Value ETF (IWN)

iShares Russell 2000 Value Index Fund (the Fund) seeks investment results that correspond generally to the price and yield performance of the Russell 2000 Value Index (the Index). The Index measures the performance of the small-capitalization value sector of the United States equity market. It is a subset of the Russell 2000 Index. The Index is a capitalization-weighted index and consists of those companies or portion of a company, with lower price-to-book ratios and lower forecasted growth within the Russell 2000 Index. The Index represents approximately 50% of the total market capitalization of the Russell 2000 Index.

The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. iShares Russell 2000 Value Index Fund's investment advisor is Barclays Global Fund Advisors.

Advisors' Opinion:

• [By John Udovich]

  Yesterday, Luna Innovations Incorporated (NASDAQ: LUNA), a rather unusual and innovative small cap stock,�soared some 23.26%���meaning its worth taking a closer look at the stock along with its performance verses the performance of small cap benchmarks like the iShares Russell 2000 Index ETF (NYSEARCA: IWM), the�iShares Russell 2000 Value Index ETF (NYSEARCA: IWN) or the iShares Russell 2000 Growth Index ETF (NYSEARCA: IWO).

Hot Dow Dividend Stocks To Own Right Now: Geospace Technologies Corp (GEOS)

Geospace Technologies Corporation, formerly OYO Geospace Corporation, incorporated on September 13, 1997, designs and manufactures instruments and equipment used in the acquisition and processing of seismic data, as well as in the characterization and monitoring of producing oil and gas reservoirs. The Company also manufactures and distributes thermal imaging equipment and dry thermal film products to a variety of markets including the screenprint, point of sale, signage and textile markets. As of September 30, 2011, OYO Corporation U.S.A. (OYO USA) owned approximately 20.3% of the Company�� common stock. The Company operates in two segments: Seismic and Thermal Solutions. The seismic segment of its business accounts for the majority of its sales. Its thermal solutions product technologies were developed for seismic data processing applications.

Seismic Products

Geoscientists use seismic data primarily in connection with the exploration, development and production of oil and gas reserves to map hydrocarbon bearing formations and the geologic structures that surround them. The Company provides many of the components of seismic data recording systems, including data acquisition systems, geophones, hydrophones, multi-component sensors, seismic leader wire, geophone strings, connectors, seismic telemetry cables and other seismic related products. Its marine seismic products help steer streamers while being towed and help recover streamers if they become disconnected from the vessel.

The Company has developed permanently installed high-definition reservoir characterization products for ocean-bottom applications in producing oil and gas fields. It also produces a retrievable version of this ocean-bottom system for use on fields where permanently installed systems are not appropriate or economical. Seismic surveys repeated over selected time intervals show dynamic changes within the reservoir and can be used to monitor the effects of production. In addition, it produc! es seismic borehole acquisition systems which employ a fiber optic augmented wireline capable of high data transmission rates. These systems are used for several reservoir characterization applications, including an application pioneered by it allowing operators and service companies to monitor and measure the results of fracturing operations.

The Company designs and manufactures power and communication transmission cable products for offshore applications and market these products to the offshore oil and gas and offshore construction industries. These products include a variety of specialized cables, primarily used in deepwater applications, such as remotely operated vehicle (ROV) tethers, umbilicals and electrical control cables. These products also include specially designed and manufactured cables, including armored cables, engineered to withstand harsh offshore operating environments. In addition, it designs and manufactures industrial sensors for the vibration monitoring, security and earthquake detection markets. The Company also design and manufacture other specialty cable and connector products, such as those used in connection with global positioning products and water meter applications.

Its seismic product lines consists of land and marine nodal seismic data acquisition systems, high-definition reservoir characterization products and services, geophones and hydrophones, including multi-component geophones and hydrophones, seismic leader wire, geophone string and acquisition system connectors, seismic telemetry cables, marine seismic cable retrieval and steering devices and specialized data acquisition systems targeted at conventional and niche markets.

The Company�� high-definition reservoir characterization products include the HDSeis product line and a suite of borehole and reservoir characterization products and services. Its HDSeis System is a high-definition seismic data acquisition system with architecture that allows it to be configured as a bo! rehole se! ismic system or as a subsurface system for both land and marine reservoir-monitoring projects. Its multi-component seismic product developments include an omni-directional geophone for use in reservoir monitoring, a compact marine three-component or four-component gimbaled sensor and special-purpose connectors, connector arrays and cases. Its products used in marine seismic data acquisition include its marine seismic streamer retrieval devices (SRDs). Its SRDs, which are attached to the streamer cables, contain air bags which are designed to inflate automatically at a given depth, bringing the severed streamer cables to the surface. It also produces seismic streamer steering devices, or birds, which are finlike devices that attach to the streamer cable. These birds help maintain the streamer cable at a certain desired depth as it is being towed through the water.

The Company competes with CGGVeritas, ION Geophysical, INOVA, Amphenol Corporation, Fairfield Industries, Petroleum Geo-Services ASA, Avalon, Mitcham Industries, Inc. and Seismic Equipment Solutions.

Thermal Solutions Products

The Company thermal printers include both thermal imagesetters for graphics applications and thermal plotters for seismic applications. In addition, its thermal solutions products include direct-to-screen systems, thermal printheads, dry thermal film, thermal transfer ribbons and other thermal media. Its thermal imaging solutions produce images ranging in size from 12 to 54 inches wide and in resolution from 400 to 1,200 dots per inch. It markets its thermal imaging solutions to a variety of industries, including the screen printing, point-of-sale, signage, flexographic and textile markets. It also distributes private label dry thermal media for use in its thermal printers and direct-to-screen systems. In addition, the Company is engaged in efforts to develop new lines of dry thermal film and ribbon in order to improve the image quality of its media for use with printheads.

The! Company thermal solutions products include thermal imagesetters for graphics applications and thermal plotters for seismic applications. In addition, its thermal solution products include thermal printheads and thermal media products. It markets these products to a variety of industries, including the screen print, point of sale, signage and textile markets. It also sells these products to seismic customers.

The Company competes with KIWO USA, Inc., Colour Scanned Technology and iSys Group.

Advisors' Opinion:

• [By Seth Jayson]

  Geospace Technologies (Nasdaq: GEOS  ) reported earnings on May 2. Here are the numbers you need to know.

  The 10-second takeaway
  For the quarter ended March 31 (Q2), Geospace Technologies whiffed on revenues and whiffed on earnings per share.

Hot Dow Dividend Stocks To Own Right Now: Sprott Physical Gold Trust (PHYS)

Sprott Physical Gold Trust (the Trust) is a closed-end mutual fund trust. The Trust was created to invest and hold substantially all of its assets in physical gold bullion. The Trust seeks to provide an exchange-traded investment alternative for investors interested in holding physical gold bullion. The Trust invests primarily in long-term holdings of unencumbered, fully allocated, physical gold bullion and does not speculate with regard to short-term changes in gold prices. Sprott Asset Management LP (the Manager) is the manager and RBC Dexia Investor Services Trust (RBC Dexia), a trust company, is the trustee of the Trust.

The Trust employs two custodians. The Royal Canadian Mint (Mint) acts as custodian for the Trust's physical gold bullion, pursuant to a precious metals storage agreement between the Manager, for and on behalf of the Trust, and the Mint, to which it refers as the precious metals storage agreement. RBC Dexia acts as custodian of the Trust's assets other than physical gold bullion pursuant to the trust agreement. As of December 31, 2010, the Trust held 90% of its total net assets in physical gold bullion in London Good Delivery bar form. The Trust does not invest in gold certificates or other financial instruments that represent gold or that may be exchanged for gold.

In making investments on behalf of the Trust, the Manager is subject to certain investment and operating restrictions, to which the Trust refers to as the Investment and Operating Restrictions. The Investment and Operating Restrictions provide that the Trust will invest in and hold a minimum of 90% of the total net assets of the Trust in physical gold bullion in London Good Delivery bar form and hold no more than 10% of the total net assets of the Trust, at the discretion of the Manager, in physical gold bullion (in London Good Delivery bar form or otherwise), gold coins, debt obligations of or guaranteed by the Government of Canada or a province of Canada or by the Government of the United St! ates or a state thereof.

The Trust will invest in short-term commercial paper obligations of a corporation or other person whose short-term commercial paper is rated R-1 (or its equivalent, or higher) by Dominion Bond Rating Service Limited or its successors, or assigns or F1 (or its equivalent, or higher) by Fitch Ratings or its successors, or assigns or A-1 (or its equivalent, or higher) by Standard & Poor's or its successors, or assigns or P-1 (or its equivalent, or higher) by Moody's Investor Service or its successors, or assigns, interest-bearing accounts and short-term certificates of deposit issued or guaranteed by a Canadian chartered bank or trust company, money market mutual funds, short-term government debt or short-term investment grade corporate debt, or other short-term debt obligations approved by the Manager from time to time. The Trust will not purchase, sell or hold derivatives.

Advisors' Opinion:

• [By Daniel Gibbs]

  Gold trusts and ETFs
  One of the easiest ways to profit off of a rising gold price is to buy shares in one of the various exchange-traded gold trusts. These are essentially closed-end funds that own physical gold bullion located in a vault. Each share of the trust represents a fractional ownership share of the physical bullion in the vault. Thus, these trusts could be an easy way to purchase gold exposure directly on an exchange. One example of a trust like this is the�Sprott Physical Gold Trust (NYSEMKT: PHYS  ) .

Hot Dow Dividend Stocks To Own Right Now: BioTime Inc (BTX)

BioTime, Inc., incorporated on November 30, 1990, is a biotechnology company focused on the emerging field of regenerative medicine. Its commercial strategy is focused on its line of research products, such as ACTCellerate cell lines and associated ESpan culture media, HyStem hydrogels, human embryonic stem (hES) cell lines, and royalties from Hextend. Its focus is to provide regenerative therapies for age-related degenerative diseases. In January 2011, the Company acquired the assets of Cell Targeting, Inc. (CTI), a biotechnology company focused on methods of painting molecules on the surface of cells, which in turn causes the cells to adhere to particular tissues, such as those afflicted with disease. On March 21, 2011, the Company acquired Glycosan BioSystems, Inc. (Glycosan) through a merger of Glycosan with OrthoCyte Corporation (OrthoCyte). Through the merger, OrthoCyte acquired all of Glycosan�� assets, including Glycosan�� Hystem hydrogel product line. In March 2011, the Company entered into an agreement with XenneX, Inc., pursuant to which it organized LifeMap Sciences, Inc. (LifeMap), a subsidiary formed to advance the development and commercialization of its human embryonic stem (hES) cell data base. In August 2011, four hES cell lines (ESI-035, ESI-049, ESI-051 and ESI-053) developed by its subsidiary ES Cell International (ESI) were approved by the National Institutes of Health (NIH) for inclusion in the NIH Human Embryonic Stem Cell Registry. In May 2012, the Company acquired XenneX, Inc., through a merger of XenneX into LifeMap Sciences. In September 2012, the Company formed a wholly owned subsidiary, BioTime Acquisition Corporation. In October 2013, Geron Corporation announced the closing of the transaction to divest the Company's stem cell assets to Asterias Biotherapeutics, Inc., a subsidiary of BioTime, Inc.

HyStem is a biomaterial, which mimics the human extracellular matrix, which is the network of molecules surrounding cells in organs and tissues which is essent! ial to cellular function. Its HyStem hydrogels may have other applications when combined with the diverse and scalable cell types its scientists have isolated from hES cells. HyStem-Rx is a clinical grade formulation of HyStem-C, a biocompatible, implantable hyaluronan and collagen-based matrix for cell delivery in human clinical applications. Its subsidiary, OncoCyte Corporation, is developing PanC-Dx, a non-invasive blood-based cancer screening test designed to detect the presence of various human cancers, including cancers of the breast, lung, bladder, uterus, stomach, and colon, during routine check -ups. BioTime Asia, Limited (BioTime Asia) sells products for research use and may develop therapies to treat cancer and neurological and orthopedic diseases in Asia. OrthoCyte Corporation (OrthoCyte) is developing therapies to treat orthopedic disorders, diseases and injuries. ReCyte Therapeutics, Inc. (ReCyte Therapeutics) is developing therapies for age-related cardiovascular and blood disorders. Cell Cure Neurosciences Ltd. (Cell Cure Neurosciences), is a biotechnology company focused on developing stem cell-based therapies for retinal and other neurological disorders, including the development of retinal pigment epithelial (RPE) cells for the treatment of age-related macular degeneration. LifeMap Sciences, Inc. (LifeMap) is advancing the development and commercialization of our embryonic stem cell database and plans to make the database available for the marketing of research products and for use by stem cell researchers at pharmaceutical and biotechnology companies and other institutions via paid subscriptions or on a fee per use basis.

The Company�� blood plasma expander product, Hextend, is a physiologically balanced intravenous solution used in the treatment of hypovolemia, a condition caused by low blood volume, often from blood loss during surgery or injury. Hextend maintains circulatory system fluid volume and blood pressure, and keeps vital organs perfused during surgery and t! rauma car! e. Hextend is manufactured and distributed in the United States by Hospira, Inc., and in South Korea by CJ CheilJedang (CJ), under license from it.

Human Embryonic Stem Cell Lines for Research Use

Combined with the Company�� ACTCellerate technology, it derives of a range of markets human embryonic progenitor cells (hEPCs). ESI�� six current good manufacturing practices (cGMP) hES cell lines have been approved by the NIH for inclusion in the Human Embryonic Stem Cell Registry, which renders those cell lines eligible for use in federally funded research. The ESI hES cell lines are available for purchase through www.biotimeinc.com. It also markets hEPCs developed using ACTCellerate technology. Its hEPCs are also available for sale through www.biotimeinc.com. It derived the complete genome sequence of five of the ESI hES cell lines to facilitate the development of products derived from these cell lines. It has made these GMP-grade cell lines, along with certain documentation and complete genomic deoxyribonucleic acid (DNA) sequence information, available for sale.

The Company offers human stem cell products and technology that can be used by researchers at universities and at companies in the bioscience and biopharmaceutical industries. It has developed research and clinical grade hES cell lines, which it markets for both basic research and therapeutic product development. It also markets human embryonic progenitor cell (hEPCs) developed using ACTCellerate technology. These hEPCs are purified lineages of cells, which are intermediate in the developmental process between embryonic stem cells and fully differentiated cells. The ACTCellerate cell lines are also available for purchase through http://www.biotimeinc.com.

Human Embryonic Progenitor Cells

Through the Company�� subsidiary ReCyte Therapeutics, it had a license from Advanced Cell Technology, Inc. (ACT) to use ACTCellerate technology, and the rights to market more than 200 human c! ell types! made using that process. ACTCellerate allows the rapid isolation of hEPCs, which are cells that are intermediate in the developmental process between embryonic stem cells and fully differentiated cells.

Through an agreement with ReCyte Therapeutics, Millipore Corporation became a global distributor of ACTCellerate hEPC lines. In addition to the products, which it is co-marketing with Millipore, it offers 92 other ACTCellerate hEPC lines for purchase at www.biotimeinc.com. Through its subsidiary LifeMap, it provides online biomedical database services to increase awareness of molecular markers and diverse cell types comprising its ACTCellerate hEPC lines. It also focuses to market additional cell types manufactured with its PureStem technology. PureStem cell lines are produced by the exogenous expression of specific transcription factors, which regulate the differentiation of cell types from hES or induced pluripotent stem (iPS) cells. BioTime Asia has an agreement with Shanghai Genext Medical Technology Co., Ltd. to sell ACTCellerate hEPC lines and related ESpan growth media to the medical and biological research communities in China, Taiwan, Hong Kong, and Macau on an exclusive basis. The marketing agreement includes provisions for an initial stocking inventory and annual milestones to maintain exclusivity. The Company�� California Institute of Regenerative Medicine (CIRM)-funded research addresses the need for industrial scale production of purified therapeutic cells.

hES Cells Carrying Genetic Diseases

The Company focuses to add to its product line muscle progenitor cells produced from five hES cell lines carrying genes for Duchenne muscular dystrophy, Emery-Dreifuss muscular dystrophy, spinal muscular atrophy Type I, facioscapulohumeral muscular dystrophy 1A, and Becker muscular dystrophy. It obtained the diseased hES cell lines from Reproductive Genetics Institute (RGI).

ESpan Cell Growth Media

The Company is marketing a range of! cell-gro! wth media products called ESpan. These growth media are optimized for the growth of hEPC types. Cells need to be propagated in liquid media, in both the laboratory setting, where basic research on stem cells is performed, and in the commercial sector. Its ESpan products are marketed through Millipore and Genext.

ESpy Cell Lines

The Company focuses for development of ESpy cell lines. The ability of the ESpy cells to emit light will allow researchers to track the location and distribution of the cells in both in vitro and in vivo studies.

HyStem Hydrogel for Research and HyStem-Rx for Cell Delivery Medical Devices

HyStem is a patented biomaterial that mimics the ECM, the network of molecules surrounding cells in organs and tissues that is essential to cellular function. Its HyStem technology forms the foundation for stem cell delivery products in both the adult and embryonic stem cell marketplace, including products manufactured using its ACTCellerate technology. As an injectable product, HyStem-Rx may address need in cosmetic and reconstructive surgeries and other procedures by transplanting adipose derived cells or other adult stem cells. The transfer of cells in HyStem-Rx localizes the transplanted cells at the intended site and by providing a three-dimensional scaffold upon which cells can rebuild normal tissue. HyStem-Rx may support other emerging cell and tissue transplant therapies, such as those derived from hES and iPS cells, in addition to its potential application in the treatment of a range of conditions such as osteoarthritis, brain tumors, stroke, bone fracture, and wounds.

Advisors' Opinion:

• [By Brian Pacampara]

  Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, biotechnology company BioTime (NYSEMKT: BTX  ) has received the dreaded one-star ranking.

• [By John Udovich]

  Stem cell stocks have not exactly been the best performers lately in part because the controversy over their use has died down over the years while major breakthroughs have been few or far between, but the industry along with small cap stem cell stocks Pluristem Therapeutics Inc (NASDAQ: PSTI), BioTime, Inc (NYSEMKT: BTX) and BioRestorative Therapies (OTCBB: BRTX) are still quietly producing their share of news or minor breakthroughs worth taking note of. Just consider the following stem cell news or news from small cap players in the sector:

Hot Dow Dividend Stocks To Own Right Now: Leggett & Platt Incorporated(LEG)

Leggett & Platt, Incorporated designs and produces various engineered components and products worldwide. Its Residential Furnishings segment offers bedding components, such as innersprings and wire forms; furniture components, including steel mechanisms, springs, seat suspensions, steel tubular seat frames, bed frames, ornamental beds, and power foundations; and structural fabrics, carpet underlay materials, and geo components. This segment serves manufacturers of finished bedding products or upholstered furniture. The company?s Commercial Fixturing & Components segment provides shelving, counters, showcases, and garment racks; standardized shelvings; point-of-purchase displays; and bases, columns, back rests, casters, and frames. This segment offers its products to retail chains and specialty shops; brand name marketers; distributors of consumer products; and office, institutional, and commercial furniture manufacturers. Its Industrial Materials segment provides steel rod s, drawn wires, steel billets, fabricated wire products, welded steel tubing, and fabricated tube components to bedding and furniture, and mechanical spring makers; automotive seating, and lawn and garden equipment manufacturers; and waste recyclers, waste removal businesses, and medical supply businesses. The company?s Specialized Products segment offers manual and power lumbar support and massage systems; seat suspension systems; automotive control cables; low voltage motors; actuation assemblies; formed metal and wire components; quilting machines; machines for shaping wire into springs; industrial sewing/finishing machines; van interiors; and docking stations, as well as specialty trailers for telephone, cable, and utility companies. It serves bedding and automobile seating manufacturers. The company sells its products through its sales representatives and distributors. Leggett & Platt, Incorporated was founded in 1883 and is based in Carthage, Missouri.

Advisors' Opinion:

• [By Dividends4Life]

  Related Articles:
  - Lockheed Martin Corp. (LMT) Dividend Stock Analysis
  - 3M Company (MMM) Dividend Stock Analysis
  - Leggett & Platt, Inc. (LEG) Dividend Stock Analysis
  - McDonald's Corporation (MCD) Dividend Stock Analysis
  - More Stock Analysis

• [By Oliver Pursche]

  I think the first step will be an increase in share-buybacks and an increase in dividends. As such, I am once again overweighting large-cap multinationals, including some great European names. My favorites include Novartis (NVS) , Legget and Platt (LEG) and Visa (V) .� Of course, the potential risk is that the cash horde remains and even grows, likely creating a deeper negative interest rate environment ��something that surely would be damaging to our economy.

• [By Dividends4Life]

  Linked here is a detailed quantitative analysis of Leggett & Platt Inc. (LEG). Below are some highlights from the above linked analysis:

  Company Description: Leggett & Platt Inc. makes a broad line of bedding and furniture components and other home, office and commercial furnishings, as well as products for non-furnishings markets.